Last update: 14 November 2006

 
 
 
 
 
 
 
 

Committees

 
 
 
  
 
 
 
 
 
   
 
 
 
 
 
 
 
 

Final Scientific Programme

Thursday, 26 October, Morning

08.00-08.30 Opening ceremony
08.30-10.30 Session 1: Epidemiology Chairperson: S Blichfeldt (DK)
08.30-08.45 What can we learn from parents and associations? J Heinemann (PWS-US)
08.45-09.00 Overview of spontaneous death report in Europe C Schrander-Stumpel (NL)
09.00-09.15 Overview of spontaneous death report in Japan T Nagai (JP)
09.15-09.30 What can we learn from KIGS database? P Wilton (KIGS)
09.30-09.45 How to run an epidemiological study? J Whittington (UK)
09.45-09.55 Multicentre studies, can they help? European PWS Research Project A Holland (UK)
09.55-10.05 Multicentre studies, can they help? NIH Rare Disorder Project D Driscoll (US)
10.05-10.30 Discussion
10.30-11.00 Coffee break
11.00-13.00 Session 2: Psychiatric and behavioral disorders Chairperson: L Curfs (NL)
11.00-11.20 Overview and mechanisms A Holland (UK)
11.20-11.40 Is there a relationship between autism and PWS? B Rogé (FR)
11.40-12.00 Does GH improve cognitive and social development? A Hokken-Koelega (NL)
12.00-12.20 Psychotic illness S Soni (UK)
12.20-13.00 Discussion
13.00-14.00 Lunch

Thursday, 26 October, Afternoon

14.00-15.30 Session 3: Breathing and sleeping abnormalities Chairperson: M Ritzen (SE)
14.00-14.20 Prevalence of breathing disorders in children D Festen (NL)
14.20-14.40 Sleep disorders: diagnosis and treatment, a practical approach B Schlueter (DE)
14.40-15.00 Is there any relationship with IGF-I levels? J Miller (US)
15.00-15.30 Discussion
15.30-16.00 Coffee break
16.00-18.00 Session 4: New insights on the genetics of PWS and their clinical relevance Chairperson: F Muscatelli (FR)
16.00-16.20 New genes involved in PWS R Nicholls (US)
16.20-16.40 Does the genotype influence our care? M Butler (US)
16.40-17.00 Imprinting defects B Horsthemke (DE)
17.00-17.20 C/D snoRNAs and the Prader-Willi syndrome J Cavaillé (FR)
17.20-18.00 Discussion
18.00-19.00 Session hot topics

Friday, 27 October, Morning

08.30-10.00 Session 5: Unresolved questions on the endocrinology of PWS Chairperson: G Chiumello (IT)
08.30-08.50 Is ghrelin involved in PWS phenotype? B Hauffa (DE)
08.50-09.10 Other gut hormones involved in appetite control A Goldstone (UK)
09.10-09.30 What is wrong with hypothalamus? D Swaab (DE)
09.30-10.00 Discussion
10.00-10.30 Coffee break
10.30-13.00 Round-table A: PWS management in infancy and childhood Chairperson: B Whitman (US)
In infancy:
10.30-10.50 Early diagnosis and multidisciplinary care M Tauber (FR)
10.50-11.10 Nutritional stages D Driscoll (US)
11.10-11.30 Physical training M Nijhuis (NL)
11.30-11.45 Break
In childhood:
11.45-12.05 Effect of GH treatment A. Carrel (US)
12.05-12.25 Scoliosis: epidemiology and management F Accadbled and T Odent (FR)
12.25-13.00 Discussion
13.00-14.00 Lunch

Friday, 27 October, Afternoon

14.00-15.30 Round-table B: Transition and adult care Chairperson: L Gourash (US)
14.00-14.20 Sex steroids replacement and bone health G Grugni (IT)
14.20-14.40 GH in transition and beyond AC Lindgren (SE)
14.40-15.00 Prevention of obesity in adults (Ethicals and legal) C Hoybye (SE)
15.00-15.20 Presentation and treatment of psychiatric disorders D Thuilleaux (FR)
and A Voegels (BE)
15.20-15.30 Discussion
15.30-16.00 Summary and closing of the meeting




 

 

To the top